A review on the evolution of immunotherapy in bladder carcinoma

Journal Title: Iberoamerican Journal of Medicine - Year 2020, Vol 2, Issue 4

Abstract

Bladder cancer is one of the most significant genitourinary cancer characterized by a high rate of recurrences, morbidity, and mortality in a large number of patients. Over the years, numerous therapeutic approaches have been developed. For more than 40 years, the most comprehensive method for the treatment of non-invasive and invasive bladder cancer has been the use of Bacillus Calmette-Guerin (BCG), giving a successful effect in a high percentage of patients. However, due to the genetic instability of cancer and the desire to develop personalized therapy, therapeutic approaches are continually evolving and improving. This review will discuss the therapeutic evolution and directions of future research to improve the efficacy of immunotherapy in the treatment of bladder carcinoma.

Authors and Affiliations

Milena Gulinac, Dorian Dikov, Simeon Lichev, Tsvetelina Velikova

Keywords

Related Articles

Therapeutic Efficacy of Functional Task with Unilateral AFO and Knee Gaiter versus Bobath Intervention on Patients Gait Dysfunction in Stroke Population - A Comparative Study

Introduction: Stroke is defined as sudden onset of focal neurological deficit lasting more than 24 hours duration. There are several complications derived from these illness, including neurological disorders like gait dy...

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2

World Health Organization (WHO) is gathering the latest scientific findings and knowledge on coronavirus disease (SARS-CoV-2) and compiling it in a database. WHO update the database daily from searches of bibliographic d...

Association Between Face Masks Use and Occupation in Cameroon: Perceived Susceptibility to COVID-19 and Physician’s Roles

Introduction: Face masks use among Cameroonians is a new behavior. Many citizens have adopted face masks as a step to prevent the spread of COVID-19. Individuals might use face masks because of their profession, risk per...

ABO blood groups among Coronavirus disease 2019 patients

Introduction: Susceptibility to some infectious diseases has been associated with blood group phenotypes. Coronavirus disease 2019 (COVID-19) is a new infectious disease caused by a novel corona virus designated Severe A...

Antiviral proteinase inhibitors of plant and animal origin

Introduction: Over the past 10 years, much attention has been paid to the development of new antiviral drugs based on the suppression of the proteolytic activity of enzymes by trypsin inhibitors of plant and animal origi...

Download PDF file
  • EP ID EP689562
  • DOI http://dx.doi.org/10.5281/zenodo.4075416
  • Views 126
  • Downloads 0

How To Cite

Milena Gulinac, Dorian Dikov, Simeon Lichev, Tsvetelina Velikova (2020). A review on the evolution of immunotherapy in bladder carcinoma. Iberoamerican Journal of Medicine, 2(4), -. https://europub.co.uk/articles/-A-689562